AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OKYO Pharma Ltd Director's Dealing 2022

May 19, 2022

Director's Dealing

Opens in your device viewer

Issuer: OKYO Pharma Ltd (OKYO)
CIK: 0001849296
Period of Report: 2022-05-19

Reporting Person: CERRONE GABRIELE M (Director, Non-Executive Chairman, 10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-19	American Depositary Shares	P	37500	$4.00	Acquired	62500	Indirect